Gedivumab [1807954-17-1]

TargetMol Chemicals

Gedivumab

9

1807954-17-1

Antibody

Research Use Only

Gedivumab

Gedivumab (MHAA4549A; RG7745), a human monoclonal antibody, exhibits high specificity in targeting the influenza A virus (IAV) by binding to the highly conserved stem region of the IAV hemagglutinin protein. This interaction inhibits hemagglutinin maturation and blocks hemagglutinin-mediated membrane fusion within the intranucleosome, making Gedivumab useful for studies on IAV infection disease [1].

3 years

-20°C

12352203